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Abstract
Background: BAMBI is a type I TGFb receptor antagonist, whose in vivo function remains unclear, as BAMBI
2/2 mice lack an
obvious phenotype.
Methodology/Principal Findings: Identifying BAMBI’s functions requires identification of cell-specific expression of BAMBI.
By immunohistology we found BAMBI expression restricted to endothelial cells and by electron microscopy BAMBI
2/2 mice
showed prominent and swollen endothelial cells in myocardial and glomerular capillaries. In endothelial cells over-
expression of BAMBI reduced, whereas knock-down enhanced capillary growth and migration in response to TGFb. In vivo
angiogenesis was enhanced in matrigel implants and in glomerular hypertrophy after unilateral nephrectomy in BAMBI
2/2
compared to BAMBI
+/+ mice consistent with an endothelial phenotype for BAMBI
2/2 mice. BAMBI’s mechanism of action in
endothelial cells was examined by canonical and alternative TGFb signaling in HUVEC with over-expression or knock-down
of BAMBI. BAMBI knockdown enhanced basal and TGFb stimulated SMAD1/5 and ERK1/2 phosphorylation, while over-
expression prevented both.
Conclusions/Significance: Thus we provide a first description of a vascular phenotype for BAMBI
2/2 mice, and provide in
vitro and in vivo evidence that BAMBI contributes to endothelial and vascular homeostasis. Further, we demonstrate that in
endothelial cells BAMBI interferes with alternative TGFb signaling, most likely through the ALK 1 receptor, which may
explain the phenotype observed in BAMBI
2/2 mice. This newly described role for BAMBI in regulating endothelial function
has potential implications for understanding and treating vascular disease and tumor neo-angiogenesis.
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Introduction
Transforming growth factor b (TGFb) is involved in the
regulation of many developmental and physiological processes,
as well as in the pathophysiology of many diseases. The multiple
and often opposing actions of TGFb are due to the cell-type
specific expression of the diverse members of the TGFb family,
their multiple receptors and signaling pathways, which can be
further influenced by cell-restricted modulator proteins [1–3].
BAMBI (BMP and Activin receptor Membrane Bound Inhibitor)
was described as such a modulator, with a putative function as a
dominant negative, non-signaling, competitive pseudo-receptor
for members of the TGFb type 1 receptor (TbR1) family [4–6].
As BAMBI is co-expressed with members of the TGFb family
during development and in cancer, it was proposed, that
BAMBI may play a role in development [7,8] and in tumor
growth and metastasis [9–11]. However the genetic elimination
of BAMBI resulted in normal development, litter size, growth
and survival of the mice [12], and thus the physiological
function of BAMBI remains unclear. The absence of an obvious
phenotype in BAMBI
2/2 mice is surprising as germ-line
deletion of members of the BMP and TGFb systems result in
major abnormalities, many of them involving the vascular
system [13–15].
We argued that the interaction of BAMBI with the TGF family
would require co-expression of the respective receptors and
BAMBI in the same cell type [1,16], so genetic elimination of
BAMBI would result in enhanced TGFb activity restricted to that
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expression of BAMBI in mammalian organs is lacking, as only
whole organ or tumor mRNA levels have been reported [9,17].
Thus a cell-restricted gain of function phenotype in BAMBI
2/2
mice could escape detection. TGFb plays an important role in
angiogenesis and signals through alternative pathways in endo-
thelial cells [13,18–24]. Furthermore we recently noted, that in
kidneys BAMBI is expressed predominantly in endothelial cells
[25]. Therefore we hypothesized, that BAMBI may play a role in
modulating endothelial biology.
We now report that BAMBI expression is restricted to vascular
endothelial cells in all major organs examined. Results of in vitro
and in vivo angiogenesis assays show that BAMBI decreases
angiogenesis, whereas BAMBI elimination enhances angiogenesis
under all experimental conditions. Furthermore BAMBI
2/2 mice
have an endothelial phenotype as evidenced by electron micros-
copy of capillaries in heart and kidney tissue, and by larger renal
glomerular capillary convolutions, which show enhanced neo-
angiogenesis during compensatory renal hypertrophy in
BAMBI
2/2 as compared to BAMBI
+/+ mice. In HUVEC the
effects of BAMBI are mediated predominantly through interac-
tions with alternative TGFb signaling through SMAD1/5 and
ERK 1/2 phosphorylation. Taken together we identify for the first
time a vascular endothelial phenotype in BAMBI
2/2 mice, and
provide evidence for a physiological role for BAMBI in endothelial
biology and vascular homeostasis, observations that may be of
considerable interest for the modification of the vascular actions of
TGFb by BAMBI, including neo-angiogenesis during tissue injury
and during tumor growth.
Methods
A detailed Methods section can be found as an online
supplement. (Methods S1).
Ethics Statement
All animal studies were carried out with compliance with the
Mount Sinai School of Medicine Institutional Animal Care and
Use Committee approved protocols (protocol number LA08-
00399).
Mice
The BAMBI
2/2 mice were generated as reported [12].
Cell Culture and Transfection
Primary human endothelial cells, HUVEC, (Lonza, Walkers-
ville, MD) were transfected with BAMBI siRNA (Silencer selected
pre-designed siRNA, Ambion, Austin, TX) using Lipofectamine
RNAiMAX (Invitrogen, Carlsbad, CA), according to the manu-
facturers’ protocol. The endothelial cell line EA.hy926 (ATCC,
Rockville, MD) was transfected with BAMBI or control lentiviral
constructs as previously described [25].
In Vitro Angiogenesis Assay
Endothelial cells were seeded on cytokine depleted Matrigel (BD
Bioscience) and cultured with/without addition of TGFb-1 (1 ng/
mL final concentration) or vehicle at 37uC. Cells were photo-
graphed using a Nikon TE2000-U microscope equipped with a
CCD camera (Diagnostic Instruments) [26].
In vivo Angiogenesis
Angiogenesis was evaluated using the modification of the
matrigel implant assay as described by Guedez et al. with the
assay kit DIVAA TM (Trevigen, USA) [27].
Transmission Electron Microscopy (EM)
EM was performed as previously reported [28]. The number of
capillaries was evaluated in heart specimens for 10 images per
organ, and expressed as number of capillaries/field. Endothelial
cell number and thickness and regularity of capillary basement
membranes were assessed for 20 randomly selected capillaries per
specimen. In kidneys, measurements were performed on 6
randomly selected capillary loops in 5 randomly selected glomeruli
per specimen.
Unilateral Nephrectomy
The right kidney of BAMBI
+/+ and BAMBI
2/2 male 6 weeks
old mice was surgically removed as previously described [29].
After two weeks, mice were sacrificed and the remaining kidney
removed for staining. Urine and blood samples were collected on
the day of operation and on the day of sacrifice. Blood urea
nitrogen (BUN) was measured by the commercial DIUR-500-
QuantiChromUrea Assay (Gentaur, USA). Proteinuria was
determined as urine albumin/creatinine ratio using ELISA
(Exocell, USA).
Statistical Analysis
Data are presented as mean 6 SEM. For all assays, statistical
analysis was performed using a Mann-Whitney test. For the
matrigel implant and the unilateral nephrectomy experiments,
where the same animal was sampled at different times, the
Wilcoxon test was used. We deemed a P,0.05 as significant. We
used Statview software for all analyses.
Results
BAMBI mRNA Levels Parallel Organ Vascularity and
BAMBI Localizes to Vascular Endothelium
BAMBI mRNA levels using two different primer pairs were
high in lung, heart and kidney, but low in liver and spleen in
BAMBI
+/+ mice, (Figure 1A). No signal for BAMBI mRNA was
detected in BAMBI
2/2 mice. By immuno-fluorescence BAMBI
localized to endothelial cells of arteries, veins, and capillaries in the
kidney, heart, and lung. In liver, only the endothelium of blood
vessels was positive for BAMBI (Figure 1B and Figure S4 for high
Figure 1. Expression of BAMBI in different mouse organs. A. Levels of mRNA (relative copy number) were determined in different organs
from BAMBI
+/+ and BAMBI
2/2 mice. Two different primer pairs were used, spanning either exons 2–3 (top panel) or exons 1–2 (bottom panel) in order
to exclude transcripts from a potential second start site in the BAMBI gene. In the tissues from the BAMBI
2/2 mice, and using either primer pair, the
levels of mRNA for BAMBI were indistinguishable from the RT minus or blank controls. Results are means 6 SEM from triplicate determinations
performed in two sets of mice. B. Immunofluorescence staining for BAMBI performed on different organs from BAMBI
+/+ and BAMBI
2/2 mice. Organs
are by rows: A: lung; B: heart; C: liver; D: kidney (g indicates glomeruli); E: femoral artery and vein; F: veins with accompagnying lymphatic vessel
(LYVE-1 staining). Magnification 400x for A, B, C and F. 200x for D and E. BAMBI staining in red (first column A–F BAMBI
+/+ mouse tissues), second
column endothelial markers in green (MECA32, BS 4 Isolectin ) and the merge in the third column in yellow. BAMBI co-localizes with endothelial
markers in all tissues, but is negative in tissues from BAMBI
2/2 mice (Inserts first column row A–D). Lymphatic endothelium stains with Lyve-1
antibody, but not with BAMBI antibody or MECA 32 (bottom row).
doi:10.1371/journal.pone.0039406.g001
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cell-specific antigens of the different organs (lectin [30], MECA-32
[31], CD31 [32]) confirmed the endothelial localization
(Figure 1B). Only background fluorescence was observed for
BAMBI in BAMBI
2/2 tissues, confirming the specificity of the
immuno-staining (Inserts Figure 1B), while staining for endothelial
markers was unaffected. By double staining with LYVE1 [33], an
antibody specific for lymphatic endothelium, lymphatic vessels
were negative for BAMBI (Figure 1B and Figure S4). Thus
BAMBI expression is restricted to vascular endothelium.
BAMBI Influences Angiogenesis in vitro
Angiogenesis was examined in vitro with either a BAMBI over-
expressing HUVEC cell line, or primary endothelial cells
transfected with siRNA for BAMBI. As controls we used respective
endothelial cells transfected with either empty vector or siScramble
RNA. Over-expression of BAMBI shortened capillary formation
and decreased branching independently of addition of TGFb at 24
hours, but at 72 hours only capillary lengths were significantly
decreased in the BAMBI overexpressing HUVEC treated with
TGFb (Figure 2 A1 and A2 and Figure S1 A). Knock-down of
BAMBI siRNA (verified by mRNA and Western blot; Figure S2)
increased capillary length with TGFb and branching indepen-
dently of TGFb addition at 48 hours as compared to scrambled
RNA (Figure 2 A3 and A4 and Figure S1 B). Taken together,
BAMBI over-expression decreases, while BAMBI knock-down
enhances in vitro angiogenesis.
BAMBI Reduces HUVEC Migration in an in vitro Scratch
Wound Assay
BAMBI’s effects on endothelial cells migration were evaluated
by in vitro scratch wound assays. BAMBI over-expression did not
influence the migration of HUVEC into the cell-free gap in the
absence of TGFb as compared to empty vector-transfected cells
(Figure 2B). TGFb markedly accelerated the cell migration, an
effect completely inhibited by BAMBI over-expression, or by the
TbRI kinase inhibitor LY364947(Figure 2B) [34]. Transfection
with scrambled RNA did not influence cell migration (siSCRAM-
BLE vs. non-transfected HUVECs: 371.8693.8 and 351.51687.9
cells/mm
2, respectively, n=3). Knock-down of BAMBI by siRNA
significantly enhanced migration in the absence of TGFb
(Figure 2C).TGFb enhanced cell migration both in the scrambled
RNA and the siBAMBI transfected HUVEC, These effects of
TGFb were inhibited by LY364947 in both scrambled and
siBAMBI transfected cells (Figure 2 C). Taken together BAMBI
over-expression abolishes the effect of TGFb on closing the scratch
gap, whereas BAMBI knock-down enhances scratch-wound
closure.
In vivo Angiogenesis is Enhanced in BAMB
2/2 Mice
To test the role of BAMBI on angiogenesis in vivo, we used
implantation of silicone tubes filled with matrigel and with or
without growth factors (VEGF and FGF), TGFb or LY364947.
Angiogenesis was significantly enhanced in the BAMBI
2/2 mice
under basal conditions as well as with addition of VEGF and FGF
(Figure 3A). Addition of TGFb to the implants had a slight, but
not significant inhibitory effect in BAMBI
+/+ mice, but markedly
inhibited the enhanced angiogenesis in BAMBI
2/2 mice (Figure 3,
B). In BAMBI
2/2 mice LY364947 prevented the inhibitory effect
of TGFb (Figure 3, B). The enhancing effect of LY36494 in the
BAMBI
2/2 mice, may be due to blockage of endogenous TGFb
generated in response to tube implantation. Taken together the in
vivo and in vitro data show that BAMBI acts as a modulator of
angiogenesis, which can be explained to a large extent by
influencing endothelial effects of TGFb.
BAMBI
2/2 Mice Show an Endothelial Phenotype
Because of their capillary density we examined kidney glomeruli
and myocardium by electron microscopy. The number of
myocardial capillaries did not differ between BAMBI
2/2 and
BAMBI
+/+ mice (BAMBI
+/+38.3; BAMBI
2/237.8 capillaries/
field). However, the number of endothelial cells per capillary cross
section was increased in BAMBI
2/2 mice from only one cell in
100% of capillary cross sections of BAMBI
+/+ myocardium to two
cells in 70% of BAMBI
2/2 hearts (Figure 4A). In renal
glomerular capillaries of BAMBI
2/2 mice, endothelial cells were
prominent as compared to BAMBI
+/+ mice (Figure 4B). The
endothelial cell bodies appeared enlarged with ‘‘activated’’ nuclei,
which markedly impinged on the capillary lumen (Figure 4C). No
changes were noted in the endothelial fenestrations, the structure,
regularity or thickness of capillary basement membranes
(basement membrane width: BAMBI
+/+213.19639.45 nm;
BAMBI
2/2207.65657.65 nm). Epithelial foot-processes were
distinct but occasionally appeared broadened. The prominence
of endothelial cells was also seen in the renal peritubular capillaries
of the BAMBI
2/2 mice (Figure 4D).
Glomeruli from BAMBI
2/2 Mice are Larger with Increased
Endothelial Capillary Areas, Changes Further Enhanced
by Compensatory Hypertrophy
Because of the glomerular changes we examined the number,
size and endothelial areas of glomeruli from adult BAMBI
+/+ and
BAMBI
2/2 mice. Total kidney weight per body weight were
comparable between BAMBI
+/+ and BAMBI
2/2 mice (Figure 5).
The number of glomeruli observed by light microscopy were not
different between BAMBI
+/+ (18869 per 4.2 mm
2 of kidney
section, n=4 mice) and BAMBI
2/2 mice (204638, n=4).
However, by computer-assisted morphometrical analysis of overall
glomerular area (determined as area within Bowman’s space on
hematoxylin and eosin stained sections) was significantly larger
(P,0.05) in BAMBI
2/2 mice (31566173 mm
2 n=86 glomeruli
analyzed from 4 mice) as compared to age and sex matched
BAMBI
+/+ mice (27496108 mm
2 n=87 glomeruli from 4 mice).
Total glomerular tuft area and glomerular endothelial area by
iso-lectin B4 staining were determined in parallel before and after
unilateral nephrectomy in BAMBI
+/+ and BAMBI
2/2 mice
(Figure S3), as the resulting compensatory hypertrophy involves
both TGFb and neo-angiogenesis [35–37]. Figure 5 shows values
Figure 2. In vitro capillary tube formation and scratch wound closing assay with endothelial cells with knock-down or over-
expression of BAMBI. A. Over-expression of BAMBI inhibits and knock-down of BAMBI enhances capillary tube formation in endothelial cells. A1
and A2. BAMBI-over-expressing or empty vector transfected endothelial cells and A3 and A4. HUVEC transfected with either scrambled RNA or siRNA
for BAMBI were plated on growth factor depleted Matrigel with or without addition of TGFb (1 ng/ml). Pictures were taken at the times indicated and
capillary tube length and branching were determined. Results are means 6 SEM, n=3.# indicates P,0.05 for comparison between groups. B and C.
Scratch wound closure is reduced by BAMBI over-expression and enhanced after knockdown of BAMBI in HUVEC. A scratch wound was created across
the respective type of HUVEC and closure of the gap observed at 24 hours by determining the number of cells in the scratch-gap. Incubations were
performed in the presence or absence of TGFb and LY364947. Results are means 6 SEM of 4 sets of independent experiments. # indicates P,0.05 for
comparison between groups and * P,0.05 for comparison to the respective basal value.
doi:10.1371/journal.pone.0039406.g002
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after 2 weeks of compensatory hypertrophy. Kidney weight per
body weight did not differ in the initial or in the samples after
compensatory hypertrophy between BAMBI
+/+ and BAMBI
2/2
mice, and the compensatory increase in kidney to body weight was
comparable (Figure 5A). In contrast, both total glomerular tufts
and isolectin B4 positive glomerular endothelial areas were
significantly larger in the initial nephrectomy specimens of
the BAMBI
2/2 mice (Figure 5B). These differences between
BAMBI
+/+ and BAMBI
2/2 mice were further enhanced after
compensatory hypertrophy (Figure 5 B and C) with coefficients of
increase for glomerular capillary areas of 2064% in BAMBI
2/2
and 962% in BAMBI
+/+ mice (P,0.05).
The endothelial changes in the BAMBI
2/2 mice did not
significantly influence glomerular perm-selectivity as evidenced by
lack of albuminuria in BAMBI
2/2 mice aged 4 to 18 weeks or at 2
weeks after unilateral nephrectomy (Table 1). Within the limits of
the quantification of the glomerular filtration rate by BUN
determination, these were comparable between BAMBI
2/2 mice
and sex and age matched BAMBI
+/+ mice either at baseline or two
weeks after unilateral nephrectomy (Table 1). Thus overall
glomerular function as indicated by BUN and urinary albumin/
creatinine ratios appeared preserved in the BAMBI
2/2 mice in
spite of the glomerular capillary obstruction from the swollen
endothelial cells seen by EM, resembling the partial capillary
occlusion during endotheliosis in e.g. pre-eclampsia [38].
Taken together these results provide the first evidence, that
BAMBI
2/2 mice exhibit an endothelial phenotype as evidenced
by their appearance on EM pictures, enhanced in vivo angiogenesis
in a modified matrigel assay and during glomerular compensatory
hypertrophy.
Changes in BAMBI’s Expression in HUVEC Predominantly
Influence Alternative TGFb Signaling with SMAD1/5 and
ERK1/2 Phosphorylation
BAMBI can modify effects of the TGFb family by acting as a
competitive inhibitor for type 1 TGFb receptors [4]. However
TGFb signaling is highly cell type specific, involving both
canonical SMAD2/3 as well as alternative pathways [1,2,39], in
part through use of different TGFb receptor combinations, which
in endothelial cells includes ALK1 [2,18–20,22,40,41]. We
therefore first examined the expression of ALK1, TbRI and
TbRII and BAMBI in the different HUVEC used for signaling
experiments (Figure 6A and D). All HUVECs showed robust
mRNA expression of ALK1 and TbRII, but low levels for TbRI,
irrespective of over-expression or knock-down of BAMBI
(Figure 6A and D) consistent with reported endothelial cell-
specific expression of ALK1 [2,18–20,22,40,41]. The canonical
TGFb pathway was analyzed by phosphorylation of SMAD3,
which exceeded SMAD2 expression in HUVEC, as also noted by
others [41]. SMAD1/5 phosphorylation was used as a read out for
alternative TGFb signaling [2,19,22]. As an additional down-
stream indicator of alternative TGFb signaling, we evaluated
ERK1/2 phosphorylation, which may modulate TGFb effects on
angiogenesis and vascular biology [39,42–47].
Over-expression of BAMBI decreased basal and TGFb-induced
SMAD1/5 phosphorylation (Figure 6 B and C). Phosphorylation of
ERK1/2 was modestly but consistently increased by TGFb in
controls(Figure 6),asalso reported byLee etal. [41]. Over-expression
of BAMBI essentially abolished the TGFb-induced phosphorylation
of ERK1/2 (Figure 6 B and C). Both basal and TGFb stimulated
phosphorylation of ERK1/2 were completely inhibited by RDEA-
119, a MAP kinase inhibitor for ERK [48]. RDEA-119 had no effects
on either SMAD3 or SMAD1/5 phosphorylation (Figure 6 B and C).
Figure 3. In vivo angiogenesis by modified-matrigel implanta-
tion assay is enhanced in BAMBI
2/2 mice in comparison to
their BAMBI
+/+ littermates. A. In vivo angiogenesis was evaluated
under basal conditions and in the presence of VEGF and FGF in the
implants in BAMBI
+/+ and BAMBI
2/2 mice. In-growth of endothelial cells
was evaluated after 12 days by isolectin B4 fluorescence determination.
Results are means 6 SEM from 4 animals per group. # P,0.05 vs.
respective basal values; * P,0.05 BAMBI
2/2 vs. BAMBI
+/+. B. Compa-
rable experiments except that TGFb 6 LY364947 or LY364947 alone
were added to the matrigel implants. Results are means 6 SEM from 5
mice per group. * P,0.05 comparing respective basal vs. growth factor
stimulated values and # P,0.05 for group comparison of BAMBI
+/+ and
BAMBI
2/2 mice in the same condition.
doi:10.1371/journal.pone.0039406.g003
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phosphorylation, but this was not consistently influenced by BAMBI
over-expression (Figure 6 B and C). The TbRI kinase inhibitor,
LY364947, inhibited the SMAD1/5 and SMAD3 phosphorylation
in both control and BAMBI over-expressing cells (Figure 6 B and C).
The reasons for the inhibition of SMAD1/5 by LY364947 are
Figure 4. Electron microscopy pictures show an activated endothelial phenotype in tissues from BAMBI
2/2 as compared to
BAMBI
+/+ mice. A. Myocardium of the BAMBI
2/2 mice is notable for the number of endothelial cells per capillary cross-section and the prominent
nuclei. In BAMBI
+/+ mice myocardial capillaries show one endothelial cell per cross-section, while those from BAMBI
2/2 mice show two nuclei per
cross-section in 70% of the capillaries (scale bar 2 mm). B and C. glomeruli from BAMBI
2/2 mice show a prominent number of endothelial cells, which
also appear swollen as compared to those from BAMBI
+/+ mice. The glomerular capillary lumen is almost obliterated by the endothelial cells in the
BAMBI
2/2 mice vs. BAMBI
+/+ (low magnification).The activated endothelial phenotype in the BAMBI
2/2 glomeruli is also apparent at higher
magnification (bottom row). D. Peritubular capillaries of BAMBI
2/2 mice also show a prominent and swollen endothelial cells impinging on the
capillary lumen as compared to BAMBI
+/+ mice.
doi:10.1371/journal.pone.0039406.g004
Figure 5. Kidney weights per body weight and glomerular and endothelial areas in the unilateral nephrectomy specimens (day 0)
and in the remaining kidneys after 14 days of compensatory hypertrophy (day 14). A. Kidney weights per body weight are comparable
between BAMBI
+/+ and BAMBI
2/2 mice and increase to a comparable degree during the 14 days of compensatory hypertrophy B and C. Glomerular
areas B. and endothelial (isolectin B4 positive) areas C. are larger in BAMBI
2/2 than in BAMBI
+/+ mice in the unilateral nephrectomy specimens and
the differences become even bigger after 14 days of compensatory renal hypertrophy. Data are mean 6 SEM, n=5 mice per group.
doi:10.1371/journal.pone.0039406.g005
BAMBI and Angiogenesis
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LY364947 did not consistently alter the response of ERK1/2
phosphorylation by TGFb in either control or BAMBI over-
expressing cells (Figure 6 B and C).
BAMBI knock-down markedly enhanced alternative TGFb
signaling with phosphorylation of SMAD1/5 and ERK1/2
(Figure 6 E and F), but SMAD3 phosphorylation also increased.
Phosphorylation of SMAD3 and SMAD1/5 were inhibited by
LY364947 and that of ERK 1/2 by RDEA-119 (Figure 6 E and
F). LY364947 also prevented the enhanced ERK1/2 phosphor-
ylation by TGFb in the HUVEC with BAMBI knock-down. Thus
the inhibition of SMAD1/5 phosphorylation by LY364947 may
result in a downstream inhibition of ERK1/2 phosphorylation,
potentially indicating a downstream effect of SMAD1/5 on ERK
activation.
Taken together, BAMBI in endothelial cells interferes predom-
inantly with the alternative TGFb signaling pathway involving
SMAD1/5 and ERK1/2. We propose that endothelial cell
restricted expression of both BAMBI and ALK1 favors alternative
signaling of TGFb, which may contribute to the effects of BAMBI
and TGFb in endothelial biology that we observed both in vitro and
in vivo.
Discussion
Our studies define for the first time a vascular endothelial
phenotype for BAMBI
2/2 mice. We demonstrate that in wild type
mice expression of BAMBI is restricted to endothelial cells, where
it acts to limit angiogenesis by interfering with alternative pathway
of TGFb signaling and thereby contributes to normal endothelial
homeostasis. Consequently genetic elimination of BAMBI results
in a vascular phenotype with prominent endothelial cells in
myocardial and glomerular capillaries, larger glomerular capillary
convolutions, and enhanced glomerular endothelial hypertrophy
after unilateral nephrectomy. Furthermore, in vivo angiogenesis
assays using matrigel implants show enhanced neo-angiogenesis in
BAMBI
2/2 mice as compared to BAMBI
+/+ mice. In vitro
angiogenesis assays further support BAMBI’s homeostatic role in
endothelial cells in that over-expression of BAMBI reduces,
whereas knock-down enhances the formation of capillary networks
and the closing of in vitro scratch wounds in HUVEC. HUVEC
express ALK1 rather than TbRI, and TGFb activates predom-
inantly alternative signaling pathways with SMAD1/5 and
ERK1/2 phosphorylation. Up or down-regulation of BAMBI in
endothelial cells influences basal and TGFb stimulated SMAD1/5
and ERK1/2 phosphorylation, which are enhanced by knock-
down of BAMBI and inhibited by BAMBI over-expression. Thus
we identify a physiological role for BAMBI in the modulation of
endothelial biology and angiogenesis through interaction with
alternative pathway activation of TGFb involving SMAD1/5 and
ERK1/2 phosphorylation.
The restricted expression of BAMBI to endothelial cells and its
interference with alternative pathways of TGFb signaling in
endothelial cells are especially intriguing as TGFb effects in
endothelial cells are highly specific. This specificity is mediated
through the use of different TGFb receptors, such as ALK1, and
involve predominantly non-canonical, alternative TGFb signaling
[13,15,20,22,49]. The importance of ALK1 and SMAD1/5 for
endothelial/vascular function is demonstrated by the observations,
that genetic elimination of either ALK1 or SMAD5 is embryonic
lethal due to cardiovascular defects [13,50] and that ablation of
ALK1 decreased tumor angiogenesis in adult mice [51]. In
contrast, conditional genetic elimination of TbRI in adult mice
does not cause a notable vascular phenotype [13,52]. Finally, the
contribution of ALK1 signaling in endothelial-vascular modeling is
supported by the observations that mutations of ALK1 have been
found in patients with type II hereditary hemorrhagic teleangiec-
tasias [38]. The predominant expression of BAMBI and ALK1 in
endothelial cells may, therefore, be ideally suited to fine tune
TGFb effects on the vasculature.
Alternative TGFb signaling can also activate neo-angiogenesis
through ERK1/2 phosphorylation [42,43,53] and ERK1/2
activation in vascular remodeling and disease has recently
attracted increased interest [43–45,47,54,55]. We demonstrate
that, in endothelial cells, endogenous BAMBI interferes with these
pathways influencing in vitro and in vivo angiogenesis. BAMBI
predominantly influences the ALK1 mediated activation of
SMAD1/5 and also alternative pathway activation leading to
ERK1/2 phosphorylation in response to TGFb in HUVEC. Thus
elimination of BAMBI in endothelial cells in vitro or in vivo tips the
balance towards a pro-angiogenic TGFb response by favoring
non-canonical pathways such as phosphorylation of SMAD1/5
and of ERK1/2.
Viewing our results on the vascular endothelial effects of
BAMBI in the scheme of TGFb signaling in endothelial cells may
explain our experimental observations. Over-expression or knock-
down of BAMBI in HUVEC respectively inhibited or enhanced in
vitro capillary tube formation, and migration in scratch wound
assays. These effects would be expected, if increased BAMBI
would inhibit and decreased BAMBI would enhance signaling
through SMAD1/5 and also ERK1/2 in endothelial cells, which
in fact we observed. The parallelism of the signaling experiments
with the in vitro endothelial experiments also extends to the in vivo
angiogenesis experiments in BAMBI
+/+ and BAMBI
2/2 mice.
Elimination of BAMBI enhanced neo-angiogenesis both under
basal and growth-factor VEGF and FGF-stimulated conditions,
indicating that BAMBI acts in an angio-static manner and thus
loss of BAMBI enhances neo-angiogenesis by activating endothe-
lial cells. Addition of LY364947 to the matrigel implants prevented
the angio-static effect of TGFb (Figure 3). We interpret this as
consistent with reports that the in vitro angio-static effects of TGFb
are mediated through activation of the canonical SMAD2/3
pathway [15,18,19]. When the canonical pathway is inhibited by
LY364947, the alternative TGFb pathways may predominate,
leading to a further enhancement in neo-angiogenesis in
BAMBI
2/2 mice. The effects of LY364947 in the absence of
exogenous TGFb, may be due to the unavoidable endogenous
TGFb generation due to the wound created at the site of the
implant.
Table 1. Albumin creatinine ratio, and BUN.
Albumin/creatinine
ratio (mg/mL) Day 0 Day 14
BAMBI
+/+ 52.463.5 (n=5) 41.268( n=5 )
BAMBI
2/2 60.4616.9 (n=4) 72.6626.2 (n=4)
BUN (mg/dL) Basal Day 14
BAMBI
+/+ 29.162.8 (n=4) 30.3963.8 (n=4)
BAMBI
2/2 28.461.3 (n=4) 29.662.9 (n=4)
Urinary albumin to creatinine ratios from BAMBI
+/+ and BAMBI
2/2 mice at
baseline and two weeks after unilateral nephrectomy. BUN levels from BAMBI
+/+
and BAMBI
2/2 mice at baseline and 2 weeks after unilateral nephrectomy.
Values are means 6 SEM for the number of animals indicated in brackets.
doi:10.1371/journal.pone.0039406.t001
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of a vascular endothelial phenotype in BAMBI
2/2 mice. The
phenotype is evident in the EM pictures of small and large blood-
vessels showing activated endothelial cells with prominent nuclei.
In the myocardium this translates into an increase in endothelial
cells with 70% of capillary cross-sections of BAMBI
2/2 mice
showing 2 endothelial cells, versus only 1 in the BAMBI
+/+ mice.
In order to quantify the vascular endothelial changes we took
advantage of the high endothelial cell density in renal glomerular
capillary convolutions, which express high levels of BAMBI, as
previously reported by us [25]. Indeed glomerular size was larger
in kidneys from BAMBI
2/2 mice than from their BAMBI
+/+
littermates. These differences were also reflected by the larger
glomerular endothelial area in the BAMBI
2/2 kidneys as
compared to those in BAMBI
+/+ kidneys, as determined by
staining with the endothelial-specific iso-lectin B4 or CD31
(Figure 5). To further evaluate in vivo angiogenesis, we examined
compensatory hypertrophy of the remaining kidney two weeks
after unilateral nephrectomy, when hypertrophy is mostly
completed [35,36]. Angiogenesis with an increase in the capillary
area is a major contributor to the compensatory hypertrophy in
glomeruli [35,36]. As expected glomerular size and endothelial
area increased in both BAMBI
+/+ and BAMBI
2/2 mice (Figure 5),
but the change in capillary and endothelial area was significantly
larger in the BAMBI
2/2 than in the BAMBI
+/+ mice, consistent
with enhanced neo-angiogenesis in the absence of BAMBI.
Why then do BAMBI
2/2 mice not show a more pronounced
vascular phenotype? The reason for this may lie in the endothelial-
specific expression and action of BAMBI, so that its elimination
will influence endothelial cells, but will not directly affect vascular
smooth muscle cells or pericytes, which play an important part in
vasculogenesis [50]. Thus the changes remain restricted to
prominent endothelial cells in a ‘‘gain of function’’ phenotype,
but not in a loss of function vascular phenotype characteristic for
mice with genetic elimination of TGFb. Furthermore, endothelial
homeostasis is maintained by a balance between the pro-
angiogenic alternative TGFb pathways and the anti-angiogenic
canonical one. Elimination of BAMBI would shift the balance
between pro- and anti-angiogenic signaling towards a pro-
angiogenic one, which could account for the endothelial pheno-
type, that we observed in the BAMBI
2/2 mice. We conclude that
changes in endothelial BAMBI levels perturb endothelial homeo-
stasis and could thereby modify vascular remodeling in tissue
injury, in a variety of diseases affecting the vascular endothelium,
such as atherosclerosis, diabetes mellitus, and kidney disease, and
even in the neo-angiogenesis of tumor growth.
Supporting Information
Figure S1 Representative pictures of in vitro capillary
tube formation. A, BAMBI over expressing endothelial cells and
theirs control at 24 h and 72 h, treated with or without TGFb,a n d
B, endothelial cells transfected with either scrambled RNA or
siRNA BAMBI at 6 h and 24 h treated with or without TGFb
(TIF)
Figure S2 Levels of mRNA for BAMBI in HUVEC after
transfection with either scrambled siRNA or siRNA for
BAMBI. Comparable results were obtained in three independent
series of experiments. Western blot for BAMBI and GAPDH from
HUVEC treated as above.
(TIF)
Figure S3 Illustration for the method used for determi-
nations of glomerular area, capillary tuft and endothe-
lial, isolectin B4 positive areas in slides from kidney
tissue. For the determination of capillary endothelial tuft, images
of frozen sections of renal cortex were taken at 20-fold
magnification, first using the appropriate fluorescence channel
for the isolectin B4 marker (FITC, 516–565 nm) and second using
differential interference contrast microscopy settings (DIC No-
marski). The left panel shows the image obtained with DIC-
Nomarski microscopy, the central one the determination of the
capillary tuft and the right picture the isolectin B4 positive area
which was determined by an observer blinded to the origin of the
slides using METAMORPH computer analysis.
(TIF)
Figure S4 Immunofluorescence staining for BAMBI
performed on different organs from BAMBI
+/+ and
BAMBI
2/2 mice.
(TIF)
Methods S1
(DOC)
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